Brian M. Nolen, Ph.D.
Affiliations: | 2011 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Public Health, OncologyGoogle:
"Brian Nolen"Parents
Sign in to add mentor| Anna E. Lokshin | grad student | 2011 | University of Pittsburgh | |
| (Circulating biomarkers in the study and early detection of ovarian cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nolen BM, Lomakin A, Marrangoni A, et al. (2015) Urinary protein biomarkers in the early detection of lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 8: 111-9 |
| Nolen BM, Breen EC, Bream JH, et al. (2014) Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma. Plos One. 9: e99144 |
| Nolen BM, Brand RE, Prosser D, et al. (2014) Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. Plos One. 9: e94928 |
| Nolen BM, Grizzle W, Brand R, et al. (2014) Abstract 295: Urine and serum biomarkers of pancreatic cancer Cancer Research. 74: 295-295 |
| Nolen BM, Orlichenko LS, Marrangoni A, et al. (2013) An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. Plos One. 8: e63368 |
| Nolen BM, Lokshin AE. (2013) Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Molecular Diagnosis & Therapy. 17: 139-46 |
| Clendenen TV, Arslan AA, Lokshin AE, et al. (2013) Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 24: 741-8 |
| Nolen BM, Lokshin AE. (2012) Multianalyte assay systems in the differential diagnosis of ovarian cancer. Expert Opinion On Medical Diagnostics. 6: 131-138 |
| Nolen B. (2012) The expansion and advancement of cancer biomarkers. Cancer Biomarkers : Section a of Disease Markers. 10: 61-2 |
| Nolen BM, Lokshin AE. (2012) Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncology (London, England). 8: 55-71 |